Position in JNJ
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$11,094,933
+$899,586 QoQ
Shares Held
43,686
+4.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.72%
of 13F equity value
Holder Rank
#1,046
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Stokes Capital Advisors, LLC holds $39,481,428 across 8 Drug Manufacturers - General names. JNJ ranks #2 (28.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
9,779 | $11,729,226 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
43,686 | $11,094,933 | |
| 3 | ABBV |
AbbVie Inc.
|
37,456 | $9,425,427 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
35,370 | $4,468,645 | |
| 5 | AMGN |
Amgen Inc
|
3,061 | $1,108,449 | |
| 6 | MRK |
Merck & Co., Inc.
|
5,373 | $690,430 | |
| 7 | PFE |
Pfizer Inc
|
22,925 | $552,034 | |
| 8 | NVO |
Novo Nordisk A S
|
8,600 | $412,284 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,094,933 | 43,686 | Shares | Other | 2026-07-22 | |
| 2026-03-31 | $10,195,347 | 41,709 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $8,475,637 | 40,955 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $7,416,058 | 39,996 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $5,764,021 | 37,735 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $6,545,207 | 39,467 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $5,665,199 | 39,173 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $6,434,106 | 39,702 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $5,996,214 | 41,025 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $7,205,870 | 45,552 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $6,577,123 | 41,962 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $6,780,109 | 43,532 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $7,462,800 | 45,087 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $7,112,175 | 45,885 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $8,019,203 | 45,396 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $7,204,502 | 44,102 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $7,885,349 | 44,422 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $7,791,739 | 43,964 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $7,112,235 | 41,575 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $6,478,895 | 40,117 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $6,452,536 | 39,168 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $5,212,360 | 31,715 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $4,774,909 | 30,340 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $4,311,118 | 28,957 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $4,560,630 | 32,430 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $4,137,151 | 31,550 | Shares | Sole | 2020-04-10 | |
| No filing history on record for this holder in this stock. | ||||||